Mild Oxidation Promotes and Advanced Oxidation Impairs Remodeling of Human High-Density Lipoprotein In Vitro

Journal of Molecular Biology

Volumn 376, Issue 4, 2008, Pages 997-1007

  Gao, Xuan ^a   Jayaraman, Shobini ^a   Gursky, Olga ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; cholesterol transport; kinetic stability; lipoprotein fusion; protein dissociation

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; COPPER; DIMER; HIGH DENSITY LIPOPROTEIN; HYPOCHLORITE; LIPID; METHIONINE; PROTEIN;

ARTICLE; CALORIMETRY; CIRCULAR DICHROISM; ELECTRON MICROSCOPY; GEL ELECTROPHORESIS; IN VITRO STUDY; LIGHT SCATTERING; LIPOLYSIS; OXIDATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; THERMOSTABILITY;

EID: 39149102137     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.12.030     Document Type: Article

References (50)

1. Fielding C.J., and Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36 (1995) 211-228
2. von Eckardstein A., Nofer J.R., and Assman G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler., Thromb., Vasc. Biol. 21 (2001) 13-27
3. Rader D.J. Molecular regulation of HDL metabolism and function: implications for novel therapies. J. Clin. Invest. 116 (2006) 3090-3100
4. Parthasarathy S., Barnett J., and Fong L.G. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta 1044 (1990) 275-283
5. Kontush A., Chantepie S., and Chapman M.J. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler., Thromb., Vasc. Biol. 23 (2003) 1881-1888
6. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84 (2004) 1381-1478
7. Navab M., Ananthramaiah G.M., Reddy S.T., Van Lenten B.J., Ansell B.J., Fonarow G.C., et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J. Lipid Res. 45 (2004) 993-1007
8. Witztum J.L., and Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold for humans?. Trends Cardiovasc. Med. 11 (2001) 93-102
9. Rohrer L., Hersberger M., and von Eckardstein A. High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr. Opin. Lipidol. 15 (2004) 269-278
10. Barter P.J., Nicholls S., Rye K.A., Anantharamaiah G.M., Navab M., and Fogelman A.M. Antiinflammatory properties of HDL. Circ. Res. 95 (2004) 764-772
11. Wu B.J., Kathir K., Witting P.K., Beck K., Choy K., Li C., et al. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J. Exp. Med. 203 (2006) 813-816
12. Bergt C., Oram J.F., and Heinecke J.W. Oxidized HDL: the paradox-idation of lipoproteins. Arterioscler., Thromb., Vasc. Biol. 23 (2003) 1488-1490
13. Pussinen P.J., Metso J., Keva R., Hirschmugl B., Sattler W., Jauhiainen M., and Malle E. Plasma phospholipid transfer protein-mediated reactions are impaired by hypochlorite-modification of high density lipoprotein. Int. J. Biochem. Cell Biol. 35 (2003) 192-202
14. Bergt C., Pennathur S., Fu X., Byun J., O'Brien K., McDonald T.O., et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc. Natl Acad. Sci. USA 101 (2004) 13032-13037
15. Nicholls S.J., Zheng L., and Hazen S.L. Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends Cardiovasc. Med. 15 (2005) 212-219
16. Peng D.Q., Wu Z., Brubaker G., Zheng L., Settle M., Gross E., et al. Tyrosine modification is not required for myeloperoxidase-induced loss of apolipoprotein A-I functional activities. J. Biol. Chem. 280 (2005) 33775-33784
17. Shao B., Oda M.N., Oram J.F., and Heinecke J.W. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr. Opin. Cardiol. 21 (2006) 322-328
18. Kontush A., and Chapman M.J. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 58 (2006) 342-374
19. Shao B., Oda M.N., Bergt C., Fu X., Green P.S., Brot N., et al. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. J. Biol. Chem. 281 (2006) 9001-9004
20. Garner B., Witting P.K., Waldeck A.R., Christison J.K., Raftery M., and Stocker R. Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol. J. Biol. Chem. 273 (1998) 6080-6087
21. Pankhurst G., Wang X.L., Wilcken D.E., Baernthaler G., Panzenbock U., Raftery M., and Stocker R. Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein. J. Lipid Res. 44 (2003) 349-355
22. Panzenböck U., and Stocker R. Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins. Biochim. Biophys. Acta 1703 (2005) 171-181
23. Artola R.L., Conde C.B., Bagatolli L., Pécora R.P., Fidelio G.D., and Kivatinitz S.C. High-density lipoprotein from hypercholesterolemic animals has peroxidized lipids and oligomeric apolipoprotein A-I: its putative role in atherogenesis. Biochem. Biophys. Res. Commun. 239 (1997) 570-574
24. Panzenböck U., Kritharides L., Raftery M., Rye K.A., and Stocker R. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I. J. Biol. Chem. 275 (2000) 19536-19544
25. Francis G.A., Mendez A.J., Bierman E.L., and Heinecke J.W. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proc. Natl Acad. Sci. USA 90 (1993) 6631-6635
26. Wang W.Q., Merriam D.L., Moses A.S., and Francis G.A. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. J. Biol. Chem. 273 (1998) 17391-17398
27. Macdonald D.L., Terry T.L., Agellon L.B., Nation P.N., and Francis G.A. Administration of tyrosyl radical-oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler., Thromb., Vasc. Biol. 23 (2003) 1583-1588
28. Pirillo A., Uboldi P., Pappalardo G., Kuhn H., and Catapano A.L. Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux. Cardiovasc. Res. 75 (2007) 566-574
29. Anantharamaiah G.M., Hughes T.A., Iqbal M., Gawish A., Neame P.J., Medley M.F., and Segrest J.P. Effect of oxidation on the properties of apolipoproteins A-I and A-II. J. Lipid Res. 29 (1988) 309-318
30. Sigalov A., and Stern L.J. Oxidation of methionine residues affects the structure and stability of apolipoprotein A-I in reconstituted high density lipoprotein particles. Chem. Phys. Lipids 113 (2001) 133-146
31. Ferretti G., Taus M., Dousset N., Solera M.L., Valdiguié P., and Curatola G. Physico-chemical properties of copper-oxidized high density lipoprotein: a fluorescence study. Biochem. Mol. Biol. Int. 30 (1993) 713-719
32. Shoukry M.I., Gong E.L., and Nichols A.V. Apolipoprotein-lipid association in oxidatively modified HDL and LDL. Biochim. Biophys. Acta 1210 (1994) 355-360
33. Kontush A., Kohlschütter A., and Beisiegel U. Physical properties of oxidized lipoproteins. Biochem. Mol. Biol. Int. 37 (1995) 707-716
34. Greilberger J., and Jurgens G. Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro. Biochem. J. 331 (1998) 185-191
35. Gursky O., Ranjana, and Gantz D.L. Complex of human apolipoprotein C-1 with phospholipid: thermodynamic or kinetic stability?. Biochemistry 41 (2002) 7373-7384
36. Mehta R., Gantz D.L., and Gursky O. Human plasma high-density lipoproteins are stabilized by kinetic factors. J. Mol. Biol. 328 (2003) 183-192
37. Jayaraman S., Gantz D.L., and Gursky O. Effects of salt on thermal stability of human plasma high-density lipoproteins. Biochemistry 45 (2006) 4620-4628
38. Rye K.A., Clay M.A., and Barter P.J. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 145 (1999) 227-238
39. Barter P.J. Hugh Sinclair Lecture: the regulation and remodeling of HDL by plasma factors. Atheroscler. Suppl. 3 (2002) 39-47
40. Malle E., Marsche G., Panzenboeck U., and Sattler W. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins. Arch. Biochem. Biophys. 445 (2006) 245-255
41. Huuskonen J., Olkkonen V.M., Jauhiainen M., Sareneva T., Somerharju P., and Ehnholm C. Oxidative modification of HDL3 in vitro and its effect on PLTP-mediated phospholipid transfer. Biochim. Biophys. Acta 1391 (1998) 181-192
42. Gómez S.L., Turchiello R.F., Jurado M.C., Boschcov P., Gidlund M., and Neto A.M. Characterization of native and oxidized human low-density lipoproteins by the Z-scan technique. Chem. Phys. Lipids 132 (2004) 185-195
43. Boullier A., Mazière J.C., Filipe P., Patterson L.K., Bartels D.M., Hug G.L., et al. Interplay of oxygen, vitamin E, and carotenoids in radical reactions following oxidation of Trp and Tyr residues in native HDL3 apolipoproteins. Biochemistry 46 (2007) 5226-5237
44. Panzenböck U., Raitmayer S., Reicher H., Lindner H., Glatter O., Malle E., and Sattler W. Effects of reagent and enzymatically generated hypochlorite on physicochemical and metabolic properties of high density lipoproteins. J. Biol. Chem. 272 (1997) 29711-29720
45. Bergt C., Oettl K., Keller W., Andreae F., Leis H.J., Malle E., and Sattler W. Reagent or myeloperoxidase-generated hypochlorite affects discrete regions in lipid-free and lipid-associated human apolipoprotein A-I. Biochem. J. 346 (2000) 345-354
46. Leeuwenburgh C., Rasmussen J.E., Hsu F.F., Mueller D.M., Pennathur S., and Heinecke J.W. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272 (1997) 3520-3526
47. Jayaraman S., Gantz D.L., and Gursky O. Effects of oxidation on the structure and stability of human low-density lipoprotein. Biochemistry 46 (2007) 5790-5797
48. Rye K.A., and Barter P.J. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler., Thromb., Vasc. Biol. 24 (2004) 421-428
49. Schumaker V.N., and Puppione D.L. Sequential flotation ultracentrifugation. Methods Enzymol. 128 (1986) 155-170
50. Benjwal S., Verma S., Röhm K.H., and Gursky O. Monitoring protein aggregation during thermal unfolding in circular dichroism experiments. Protein Sci. 15 (2006) 635-639